brimonidine tartrate; timolol maleate · Abbvie · NDA 021398
Combigan
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 021398-0011 Jul 2026
- 25 Oct 2026Generic approved · 021398-00111 Jun 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021398 · 001 · RLD | solution/drops, ophthalmic | 0.2%;EQ 0.5% BASE | open |